New York state investigators found expired Fentanyl, counterfeit Propofol, and used needles in sharps containers during inspections of businesses offering appearance enhancement and medical procedures, posing immediate health risks to consumers. These discoveries by the New York Department of State expose a critical failure in basic safety enforcement. While traditional professional services struggle with fundamental safety and licensing checks, New York is simultaneously moving to regulate complex AI advice with a private right of action. New York's dual focus on physical safety and digital advice positions its regulatory framework as a likely benchmark for other jurisdictions facing similar challenges in 2026 safety regulations compliance.
Physical Safety Failures Persist
The New York Department of State investigated 223 businesses offering appearance enhancement and medical procedures. Inspections uncovered severe safety violations. Investigators found expired and suspected counterfeit products, including Fentanyl, Xylocaine, and Propofol, alongside used needles in sharps containers, according to the New York Department of State. Compounding these material risks, numerous individuals without appropriate licenses were providing medical services such as injections, laser liposuction, and cryotherapy. Widespread non-compliance in critical health and beauty services demonstrates a fundamental breakdown in oversight, directly endangering consumers.
Proactive AI Regulation Emerges
New York is pursuing a different approach for AI. A bill under consideration would prohibit AI chatbots from providing legal or medical advice. This proposed legislation allows users to sue chatbot owners who violate the ban, establishing a private right of action, as reported by StateScoop. Chatbot owners must also provide clear notice that users are interacting with an AI system; this notice does not absolve owners of liability. New York's aggressive stance holds AI chatbot owners directly liable, shifting the primary burden of responsible AI deployment onto technology developers. New York's aggressive stance sets a potentially costly precedent for the tech industry.
